Picture of Mentari Therapeutics logo

INM — Mentari Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Brief: InMed Pharmaceuticals Announces Publication Of Peer-Reviewed Article On The Use Of Cbn As A Potential Treatment For Glaucoma

Dec 20 (Reuters) - InMed Pharmaceuticals Inc  INM.O :
    * INMED PHARMACEUTICALS ANNOUNCES PUBLICATION OF
PEER-REVIEWED
ARTICLE ON THE USE OF CBN AS A POTENTIAL TREATMENT FOR GLAUCOMA

Source text for Eikon:  ID:nGNXc3fbGM 
Further company coverage:  INM.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Mentari Therapeutics

See all news